Stanford University
Stanford, California, 94305, United States
NCT Number: NCT05123612
The purpose of the study is to learn how different dietary interventions affect microbiota diversity in pregnant women and the transmission of microbiota to their infants during pregnancy, birth, and postpartum.
This study is active but is not currently recruiting participants.
18 year–50 year
Female
Interventional
Not applicable
Stanford, California, 94305, United States
This research study aims to understand the relationship of dietary fiber, fermented foods, and the microbiome, specifically during pregnancy and postpartum. The investigators know that the composition of the microbiome can have an important effect on overall health, and a greater variety will confer more health benefits. Research suggests that maternal microbiota play an important role in the development of their offspring's microbiota during pregnancy, childbirth, and breastfeeding. The purpose of this study is to assess how diet impacts maternal microbiome during pregnancy and their infant's microbiome up to about two years postpartum.
Potential pregnant participants will be recruited during their first trimester up to 22 weeks. After completion of the baseline visit and sample collection, they will be randomized to start a diet high in fiber, high in fermented foods, high in both fiber and fermented foods, or a usual care group. Participants will be asked to provide blood, stool, vaginal swab, and breast milk samples periodically throughout the study. Cord blood will be collected after childbirth, and infant blood from a heel stick will be collected twice. They will also be asked to fill out online questionnaires and perform dietary recalls with study diet assessors.
After completing the study, participants will be invited to continue to participate in an extension of the study for approximately three and a half additional years. The purpose of this extension is to continue to assess how diet impacts the mother's microbiome postpartum and the child's microbiome up to about 5 years of age.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Medications:
If taken in the past 2 months:
Diet & Lifestyle:
Maternal chronic medical conditions:
Pregnancy history:
Additional 20 grams of fiber/day.
6 servings of fermented foods/day
Time frame: 1 month postpartum
Difference in total number of species (ASVs - Amplicon Sequence Variants) detected in stool between the fiber, fermented, fiber + fermented and comparator arms at 1 month postpartum.
Time frame: Baseline and 36 weeks of pregnancy
Change in differences in total number of species (ASVs- Amplicon Sequence Variants) detected in stool from baseline to 36 weeks of pregnancy between fiber, fermented, fiber + fermented, and comparator arms.
Time frame: Baseline and 36 weeks of pregnancy
Change in the differences in inflammatory markers (β-NGF, LIF-R, IL-12B, IL10, CASP-8, LAP TGF-β-1, CD6, CD5, MCP-2, IL6, CCL20, IL18, VEGFA, MMP-10, MCP-4, CCL4, CXCL10, CCL19, FGF-21) detected in blood samples from baseline to 36 weeks of pregnancy between fiber, fermented, fiber + fermented, and comparator arms.
Time frame: 6 months postpartum
Difference in amount of inflammatory markers (β-NGF, LIF-R, IL-12B, IL10, CASP-8, LAP TGF-β-1, CD6, CD5, MCP-2, IL6, CCL20, IL18, VEGFA, MMP-10, MCP-4, CCL4, CXCL10, CCL19, FGF-21) detected in heel stick blood between fiber, fermented, fiber + fermented, and comparator arms at 6 months postpartum.
Time frame: 6 months postpartum
Difference in amount of allergy markers (skin prick testing) detected in heel stick blood between fiber, fermented, fiber + fermented, and comparator arms at 6 months postpartum.
Time frame: 18 months postpartum
Difference in weight-for-length growth chart percentiles between fiber, fermented, fiber + fermented, and comparator arms at 18 months postpartum.
Time frame: 36 weeks of pregnancy
Differences in the number of participants who gained weight within the pregnancy weight gain recommendations between fiber, fermented, fiber + fermented, and comparator arms measured at 36 weeks.
Time frame: Baseline and 36 weeks of pregnancy
Change from baseline in systolic blood pressure at 36 weeks of pregnancy.
Time frame: Baseline and 36 weeks of pregnancy
Change from baseline in diastolic blood pressure at 36 weeks of pregnancy.
Time frame: Baseline and 36 weeks of pregnancy
Change from baseline in LDL cholesterol at 36 weeks of pregnancy.
Time frame: Baseline and 36 weeks of pregnancy
Change from baseline in HDL cholesterol at 36 weeks of pregnancy.
Time frame: Baseline and 36 weeks of pregnancy
Change from baseline in triglycerides at 36 weeks of pregnancy.
Time frame: Baseline and 36 weeks of pregnancy
Change from baseline in glucose at 36 weeks of pregnancy.
Time frame: Baseline and 36 weeks of pregnancy
Change from baseline in fasting insulin at 36 weeks of pregnancy.
Stanford University
Other
Effects of Fermented & Fiber-rich Foods on Maternal & Offspring Microbiome Study
Acronym: MOMS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05552053
Anxiety, Anxiety Disorders
Los Angeles, California, United States
View Trial DetailsNCT04962477
Inflammation, Innate Inflammatory Response
St Louis, Missouri, United States
View Trial DetailsNCT03504319
Behavior, Body Weight
Bowling Green, Kentucky, United States
View Trial DetailsNCT06417411
Anemia, Anemia, Hemolytic
Luanda, Luanda Province, Angola
View Trial Details